1. CONSORT Checklist
The trial has been registered with the US Government Clinical Trials database. See http://clinicaltrials.gov/ct/show/NCT00127465
PAPER SECTION | Description | |
1. TITLE & ABSTRACT | 1 | The title is Randomised trial.... The abstract includes Design: Randomised trial with 8 groups |
2. INTRODUCTION Background | 2 | The rationale is explained in Introduction |
3. METHODS Participants | 3 | Eligibility criteria for participants are described in methods. Patients excluded and recruited, and the setting where the data were collected, are described below (in 14). |
Interventions | 4 | Details are given in methods and in web extra 3. |
Objectives | 5 | Details given at the end of Introduction. |
Outcomes | 6 | Details given in methods. |
Sample size | 7 | Sample size calculations are shown below. There were no interim analyses or stopping rules. |
Randomization -- | 8 | See below |
Randomization -- | 9 | See below |
Randomization -- | 10 | See below |
Blinding (masking) | 11 | Participants could not be blinded for this type of intervention. Outcomes were assessed by self completed questionnaire. |
Statistical methods | 12 | This is described in methods with additional detail being given below. |
13. RESULTS Participant flow | 13 | See Figure 1. Flow of participants by three intervention factors is shown below. |
Recruitment | 14 | Details given below |
Baseline data | 15 | Baseline demographic and clinical characteristics of each group are given in the text and in Table 1. There were no significant differences between intervention factors. |
Numbers analyzed | 16 | Number of participants in each group included in each analysis is shown in Figure 1. Analysis was by "intention-to-treat" although the main analysis presented does not include those lost to follow-up as we think this presents a clearer picture. Full intention to treat analysis is presented below. |
Outcomes and estimation | 17 | There are no major differences apart from the percentage showing the booklet to their confidant; a 95% confidence interval is given for that percentage. |
Ancillary analyses | 18 | Most analyses were pre-specified. |
Adverse events | 19 | The slightly greater drop out rate for those allocated to anxiety management advice groups is described below. |
DISCUSSION | 20 | Although all statistically significant results are reported they have only been taken as robust when supported by other outcomes. |
Generalizability | 21 | See discussion. |
Overall evidence | 22 | See discussion. |